Suchergebnisse - (Subject:"Drug repurposing")

PubPharm (3.921)

71

Repurposing of Compounds from Streptomyces spp. as Potential Inhibitors of Aminoacyltransferase FemA : An Essential Drug Target against Drug-resistant Staphylococcus aureus

enthalten in: Current computer-aided drug design | 2024

von Goodarzi, N. | Shahbazi, B. | Khiavi, E. | +3

72

scDrugPrio: a framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases

enthalten in: Genome medicine | 2024

von Schäfer, S. | Smelik, M. | Sysoev, O. | +14

73

Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors

enthalten in: Molecular informatics | 2024

von Ali, W. | Jamal, S. | Gangwar, R. | +6

74

Repurposing empagliflozin in individuals with glycogen storage disease Ib : A value-based healthcare approach and systematic benefit-risk assessment

enthalten in: Journal of inherited metabolic disease | 2024

von Derks, T. | Venema, A. | Köller, C. | +9

75

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome

enthalten in: Antiviral research | 2024

von Bogacheva, M. | Kuivanen, S. | Potdar, S. | +16

76

Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages

enthalten in: European journal of pharmacology | 2024

von Chaffey, L. | Roberti, A. | Bowman, A. | +4

77

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway

enthalten in: Oncology letters | 2024

von Hsu, J. | Leu, W. | Hsu, L. | +2

78

Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7)

enthalten in: Heliyon | 2024

von Zadi, S. | Javaid, S. | Atia-Tul-Wahab | +4

79

Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2024

von Mostkowska, A. | Rousseau, G. | Raynal, N.

80

The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol

enthalten in: BioFactors (Oxford, England) | 2024

von Makk-Merczel, K. | Varga, D. | Hajdinák, P. | +1